Asset Allocation

As of March 31, 2026.
Type % Net
Cash 0.02%
Stock 91.47%
Bond 0.00%
Convertible 0.00%
Preferred 0.00%
Other 8.51%
View Asset Allocation
Start Trial

Market Capitalization

As of March 31, 2026
Large 77.27%
Mid 14.97%
Small 7.77%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 81.31%    % Emerging Markets: 10.19%    % Unidentified Markets: 8.51%

Americas 30.33%
30.33%
United States 30.33%
0.00%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 34.31%
United Kingdom 9.42%
23.54%
Denmark 0.91%
France 11.99%
Germany 4.99%
Ireland 3.11%
Netherlands 2.53%
1.36%
Turkey 1.36%
0.00%
Greater Asia 26.85%
Japan 0.83%
1.31%
Australia 1.31%
15.88%
Hong Kong 6.09%
South Korea 4.87%
Taiwan 4.92%
8.83%
China 5.55%
India 2.50%
Philippines 0.78%
Unidentified Region 8.51%

Stock Sector Exposure

Cyclical
31.16%
Materials
4.30%
Consumer Discretionary
10.07%
Financials
16.79%
Real Estate
0.00%
Sensitive
54.17%
Communication Services
24.65%
Energy
7.08%
Industrials
9.69%
Information Technology
12.75%
Defensive
5.69%
Consumer Staples
2.98%
Health Care
2.71%
Utilities
0.00%
Not Classified
8.98%
Non Classified Equity
0.00%
Not Classified - Non Equity
8.98%
As of March 31, 2026
View Region Exposure
Start Trial

Stock Style Exposure

Large Cap Value --
Large Cap Core --
Large Cap Growth --
Mid Cap Value --
Mid Cap Core --
Mid Cap Growth --
Small Cap Value --
Small Cap Core --
Small Cap Growth --
No Data Available